Casi Pharmaceuticals Inc (CASI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 3,075 | 4,175 | 6,240 | 13,356 | 7,793 |
| Cost of Goods | 2,369 | 2,117 | 2,621 | 10,128 | 3,748 |
| Gross Profit | 706 | 2,058 | 3,619 | 3,228 | 4,045 |
| Operating Expenses | 11,752 | 13,300 | 14,619 | 16,270 | 13,257 |
| Operating Income | -10,677 | -11,125 | -10,379 | -12,914 | -8,464 |
| Interest Expense | 195 | 244 | 197 | 285 | 204 |
| Other Income | -11 | -2,006 | -174 | -1,171 | 273 |
| Pre-tax Income | -10,883 | -13,375 | -10,750 | -14,370 | -8,395 |
| Net Income Continuous | -10,883 | -13,375 | -10,750 | -14,370 | -8,395 |
| Net Income | $-10,883 | $-13,375 | $-10,750 | $-14,370 | $-8,395 |
| EPS Basic Total Ops | -0.67 | -0.86 | -0.69 | -0.78 | -0.55 |
| EPS Basic Continuous Ops | -0.68 | -0.86 | -0.69 | -0.78 | -0.55 |
| EPS Diluted Total Ops | -0.67 | -0.86 | -0.69 | -0.78 | -0.55 |
| EPS Diluted Continuous Ops | -0.68 | -0.86 | -0.69 | -0.78 | -0.55 |
| EPS Diluted Before Non-Recurring Items | -0.67 | -0.86 | -0.69 | -0.79 | -0.55 |
| EBITDA(a) | $-10,677 | $-11,125 | $-10,379 | $-12,914 | $-8,464 |